What is Carmat SA's current stock price?

Carmat SA (ALCAR.PA) currently trades at EUR 0.0990. Track real-time price changes and historical performance on AllInvestView.

What sector is Carmat SA in?

Carmat SA operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Carmat SA ALCAR.PA · Stock Open Carmat SA in new tab

0.0990 EUR

Add to portfolio

EPS

-1.15

P/B

-0.12

Beta

1.02

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Carmat SA (ALCAR.PA)

Currency: EUR

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Carmat SA Analysis (ALCAR.PA)

France Health Care Official Website Stock

Is Carmat SA a good investment? Carmat SA (ALCAR.PA) is currently trading at 0.0990 EUR.

Earnings Schedule: Carmat SA is expected to release its next earnings report on Sept. 16, 2026. The market consensus estimate for Forward EPS is -2.34.

Investor FAQ

Does Carmat SA pay a dividend?

No, it does not currently pay a dividend.

What asset class is Carmat SA?

Carmat SA is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Sept. 16, 2026. The company currently has a trailing EPS of -1.15.

Company Profile

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Exchange Ticker

FRA (Germany) CXT.F

IST (Turkey) ALCAR.IS

PNK (United States) CKMTF

PAR (France) ALCAR.PA

Trades

Dividend History paid per year (EUR)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
July 13, 2011	1.02

Carmat SA ALCAR.PA · Stock Open Carmat SA in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Carmat SA Analysis (ALCAR.PA)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Carmat SA ALCAR.PA · Stock Open Carmat SA in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Carmat SA Analysis (ALCAR.PA)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications